When stratified by chemotherapeutic regimen, the seroprotection rates of serotypes 5 and 18C were lower in arm B in patients treated with fluoropyrimidine, although this did not reach statistical significance (p=0.312 for serotype 5 and p=0.120 for serotype 18C) ( S8 Table , S7B Fig. ).
← all excerpts
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial.
1
0.3120
0.3120